The chemical class referred to as 4933402P03Rik inhibitors involves compounds designed to inhibit the activity of the 4933402P03Rik gene product. This gene, which has been cataloged in mice but might have homologs in other organisms, encodes for a protein with currently limited functional annotation. However, its involvement in various molecular pathways can be inferred from gene expression studies and potential protein interactions. Inhibitors of this class are of interest to researchers due to their ability to modulate the biochemical processes in which the 4933402P03Rik protein is involved. These inhibitors are typically small molecules that bind to the active site or allosteric sites of the protein, thereby interfering with its function. The development and study of such inhibitors help researchers probe the functional role of 4933402P03Rik in specific cellular processes, providing insight into the molecular mechanics that govern these pathways.
The design of 4933402P03Rik inhibitors often relies on techniques such as structure-based drug design, where high-resolution models of the target protein guide the optimization of inhibitory molecules. Additionally, computational approaches, including molecular docking and virtual screening, are employed to identify lead compounds that exhibit a high affinity for the protein's binding sites. Once identified, these compounds undergo rigorous testing to confirm their binding efficacy, typically through biochemical assays like enzyme-linked immunosorbent assays (ELISA) or surface plasmon resonance (SPR). Understanding how these inhibitors affect the 4933402P03Rik protein function allows researchers to map its role within broader biological systems, providing insights into its regulatory mechanisms and involvement in cellular signaling or metabolic pathways. This exploration of molecular interactions enables a deeper understanding of the structural and functional nuances of the target protein, which is critical for advancing the knowledge of its role within complex biological networks.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor that can affect protein synthesis and possibly influence Spem2 expression or function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor that can alter downstream signaling pathways which may indirectly affect Spem2 activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
MEK inhibitor that can interfere with the MAPK/ERK pathway and potentially affect Spem2-related signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor which may modify inflammatory response pathways and potentially influence Spem2 activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Another MEK inhibitor that can suppress the MAPK/ERK pathway and may indirectly affect Spem2. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor which can impact cellular stress response pathways that might be related to Spem2. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor that may alter cell survival and growth signals, potentially affecting Spem2. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Src kinase inhibitor which can affect multiple signaling pathways and may have an indirect effect on Spem2. | ||||||
NF449 | 627034-85-9 | sc-478179 sc-478179A sc-478179B | 10 mg 25 mg 100 mg | $203.00 $469.00 $1509.00 | 1 | |
Gs-alpha subunit-specific antagonist that can impact signal transduction and possibly influence Spem2. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Src family kinase inhibitor which might alter signaling pathways that regulate Spem2 expression or function. | ||||||